Medicare Advisors Mostly Favor TAVR Center Volume Thresholds

The Medicare Evidence Development & Coverage Advisory Committee looked at the evidence for procedural volume requirements that hospitals and heart-team members currently must meet to perform transcatheter aortic valve replacements versus the prospect of quality measures as a condition of coverage. The discussion at a meeting held this week will inform the US Medicare agency's ongoing reconsideration of its TAVR coverage policy.

Edwards' Sapien 3 Transcatheter Aortic Valve • Source: Edwards Lifesciences

A group of Medicare advisors generally supported maintaining procedure-volume requirements for physicians and hospitals as a basis for covering transcatheter aortic valve replacement (TAVR) procedures during a July 25 meeting. But some in the medical and device-maker community argued that the emphasis must shift away from volume and toward quality measures.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Policy & Regulation

More from Medtech Insight